Get App Open
In App
Credit Cards
Open App
you are here:
Success
Alert
Please select a Day.
Info

GlaxoSmithKline Pharmaceuticals Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs

2,728.40
154.10 (5.99%)

As on 08 Apr, 2025 | 03:56

Day Range
2602.05
2745.45
L H
52 Week Range
1842.05
3088.00
L H
Volume
133,036
*
i

* BSE Market Depth (08 Apr 2025)

BUY SELL
QTY PRICE PRICE QTY
50 2700.00 2740.00 31
50 2690.00 2744.00 10
1 2676.70 2744.05 4
1 2676.20 2745.00 3
1 2667.50 2745.90 3
0 Total Total 0
Bid / Ask
0.00 / 0.00
2,709.00
131.85 (5.12%)

As on 08 Apr, 2025 | 04:01

Day Range
2609.00
2745.50
L H
52 Week Range
1825.05
3087.95
L H
Volume
5,236
*
i

* BSE Market Depth (08 Apr 2025)

BUY SELL
QTY PRICE PRICE QTY
50 2700.00 2740.00 31
50 2690.00 2744.00 10
1 2676.70 2744.05 4
1 2676.20 2745.00 3
1 2667.50 2745.90 3
0 Total Total 0
Bid / Ask
0.00 / 0.00
NSE
MC Essentials
71% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Superior Financial Strength, High Growth Trend Stock Priced at High Valuations

Financials
    Ownerships
      Industry Comparison
        Others
          Open 2,640.00
          Previous Close 2,574.30
          Volume 133,036.00
          Value (Lacs) 3,629.75
            VWAP 2,705.54
          Beta
          Mkt Cap (Rs. Cr.) 46,221
          High 2,745.45
          Low 2,602.05
          UC Limit 3,089.15
          LC Limit 2,059.45
          52 Week High 3,088.00
          52 Week Low 1,842.05
          Face Value 10.00
          All Time High 3,088.00
          All Time Low 110.00
          20D Avg Volume 153,527
          20D Avg Delivery(%) 34.69
          Book Value Per Share 98.74
          Dividend Yield 1.17
          TTM EPS See historical trend 50.72 (+45.64% YoY)
          TTM PE See historical trend 53.79 (Average PE)
          P/B See historical trend 27.64 (High P/B)
          Sector PE 43.36

          Advanced Chart

          Click here to expand

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Superior Financial Strength, High Growth Trend Stock Priced at High Valuations

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 11.65% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Above Median

          Shareholding Pattern
          • Promoter holding remains unchanged at 75.00% in Dec 2024 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          SCANS

          Companies that are Improving efficiency in utilising shareholders funds

          Companies increasing efficiency in utilisation of all sources of capital

          Scan lists companies in which Promoter holding exceeds 70%

          Debt Free Companies

          Companies in which FIIs have increased holding QoQ

          Companies trading at more than 5 times their book values

          Powered by: Definedge

          Price and Volume

          Price Performance
          1 Week
          --%
          1 Month
          --%
          3 Months
          --%
          YTD
          --%
          1 Year
          --%
          3 Years
          --%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          9 out of 17 years GlaxoSmithKline Pharmaceuticals has given negative returns in April.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          April 14.86% (2020) 7.82% -9.04% (2017) -5.35% 0.84%

          Forum

          Community Sentiments

          • 0% BUY
          • 100% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend selling GlaxoSmithKline

          What's your call on GlaxoSmithKline today?

          Read 2 investor views

          BUY SELL HOLD

          Broker Research

          No Data For Broker Research.

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          No Data For Bulk Deals.

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Insider Transaction Summary

          30 Mar, 2017

          GlaxoSmith Kline Pet Ltd

          Promoter
          Qty 3192238 Price 2725 % Traded 1.88 Post Tnx Hold. 28.1%
          30 Mar, 2017

          Castleton Investment Ltd

          Promoter
          Qty 3192238 Price 2725 % Traded 1.88 Post Tnx Hold. 0%

          *Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015

          14 Sep, 2022

          Life Insurance Corporation of India Disposal

          Other
          Qty 3463785 Price 0 % Traded 2.04 Post Tnx Hold. 4.35%
          20 Dec, 2019

          Life Insurance Corporation of India Disposal

          Other
          Qty 3402936 Price 0 % Traded 2.00 Post Tnx Hold. 5.99%
          30 Mar, 2017

          GlaxoSmithKline Pte Ltd Acquisition

          Other
          Qty 3192238 Price 0 % Traded 3.77 Post Tnx Hold. 0%
          30 Mar, 2017

          GlaxoSmithKline Pte Ltd & Others Acquisition

          Promoter
          Qty 3192238 Price 0 % Traded 3.77 Post Tnx Hold. 28.1%
          30 Mar, 2017

          GlaxoSmithKline Pte Ltd and PACs Disposal

          Promoter
          Qty 3192238 Price 0 % Traded 3.77 Post Tnx Hold. 0%
          21 Mar, 2017

          GlaxoSmithKline Pte Ltd (Revised) Acquisition

          Promoter
          Qty 3192238 Price 0 % Traded 3.77 Post Tnx Hold. 0%

          *Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

          Financials

          Created with Highstock 6.2.03224.383224.382925.62925.63278.033278.033251.723251.723453.713453.71Revenue2020202120222023202402k4k
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Shareholding

          Summary

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE(%) 1 Yr Perform(%) Net Profit(Rs.) Net Sales(Rs.) Debt to Equity
          GlaxoSmithKline 2,728.40 5.99 46,220.74 53.79 27.63 33.42 41.38 589 3,453 0.00
          Sun Pharma 1,688.35 1.32 405,091.72 35.40 5.86 15.04 5.54 9,648 48,496 0.04
          Divis Labs 5,387.30 2.44 143,015.89 69.19 10.43 11.78 41.92 1,600 7,845 0.00
          Cipla 1,432.55 3.46 115,695.19 23.19 4.08 15.43 -2.04 4,155 25,774 0.01
          Torrent Pharma 3,246.60 0.40 109,879.70 59.01 14.64 24.15 25.00 1,656 10,727 0.57

          About the Company

          GlaxoSmithKline Pharmaceuticals Ltd. (GSK Rx India) is one of the oldest pharmaceuticals company. The GSK India product portfolio includes prescription medicines and vaccines. Their prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease and respiratory diseases. The company is the market leader in most of the therapeutic categories in which it operates. GSK also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, streptococcus pneumonia and others.
          {"success":1,"data":{"address":{"address1":"GSK House,","address2":"Dr. Annie Besant Road,,Worli,","city":"Mumbai","state":"Maharashtra","pincode":"400030","telephone1":"022-24959595","telephone2":"","fax1":"022-24959494","fax2":"","email":"in.investorquery@gsk.com","web":"http:\/\/www.gsk-india.com"},"management":[{"name":"R S Karnad","designation":"Chairperson"},{"name":"B Akshikar","designation":"Managing Director"},{"name":"J Chandy","designation":"WholeTime Director & CFO"},{"name":"S Williams","designation":"Non Executive Director"},{"name":"M Anand","designation":"Independent Director"}],"registrars":{"name":"KFin Technologies Ltd.","address1":"Selenium Tower B, Plot No. 31-32,","address2":"Gachibowli, Financial District, \nNanakramguda,Seri","address3":"","address4":"","telephone":"040-67161500, 67162222, 33211000","fax":"040-23420814, 23001153","email":"einward.ris@karvy.com","internet":"http:\/\/www.kfintech.com","city":"Hyderabad","state":"Telangana","pincode":"500032"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"Yes"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"Yes"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"500660","nseId":"GLAXO","series":"EQ","isinid":"INE159A01016"}}}
          • Registered Office

          • Registrars

            • Address

              Selenium Tower B, Plot No. 31-32,,Gachibowli, Financial District, Nanakramguda,Seri

            • City

              Hyderabad 500032

            • State

              Telangana

            • Tel. No.

              040-67161500, 67162222, 33211000

            • Fax No.

              040-23420814, 23001153

            • Email

              einward.ris@karvy.com

            • Internet

              http://www.kfintech.com

          • Management

            • R S Karnad

              Chairperson

            • B Akshikar

              Managing Director

            • J Chandy

              WholeTime Director & CFO

            • S Williams

              Non Executive Director

            • M Anand

              Independent Director

          • Included In

            • BSE 100

              No

            • BSE 200

              Yes

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              Yes

            • Nifty 200

              No

          • Details

            • BSE:

              500660

            • NSE:

              GLAXO

            • Series

              EQ

            • ISIN

              INE159A01016

          1